Does microscopic positive tumor margin in papillary thyroid cancer really matter?

被引:7
|
作者
Back, Kyorim [1 ]
Kim, Seo Ki [2 ]
Chai, Young Jun [3 ]
Kim, Jung-Han [1 ]
Choe, Jun-Ho [1 ]
Kim, Jee Soo [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrine Surg,Dept Surg, 81 Irwon Ro, Seoul 135710, South Korea
[2] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea
[3] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Surg, Seoul, South Korea
关键词
PREOPERATIVE ULTRASONOGRAPHY; ASSOCIATION GUIDELINES; SURGICAL-MANAGEMENT; RECURRENCE; CARCINOMA; SURVIVAL; INCREASE; SURGERY; THERAPY;
D O I
10.1016/j.surg.2019.07.021
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The clinical impact of microscopically positive tumor margin in papillary thyroid cancer is not well studied. The aim of this study is to evaluate the clinical importance of a microscopically positive margin for recurrence in papillary thyroid cancer patients and to examine whether recurrence and recurrence-free survival were affected by the location of the positive margin-anterior or posterior. Methods: We conducted a retrospective cohort study at a single institution. From January 1997 to June 2015,6,293 papillary thyroid cancer patients who underwent total thyroidectomy with or without neck dissection (central and/or lateral) at the Thyroid Cancer Center of Samsung Medical Center (Seoul, South Korea) were included in the analyses. Results: Of the 6,293 papillary thyroid cancer patients, an operative margin was microscopically involved in 313 (5.0%) on final pathologic report. The mean follow-up time was 77.5 months, and locoregional recurrence was observed in 244 (3.9%) patients. The presence of a microscopically positive margin did not increase the risk of locoregional recurrence (adjusted hazard ratio = 1.079, P = .140) after adjustment for other statistically significant factors in the Cox proportional hazard model. In addition, posterior positive margin was not a risk factor for locoregional recurrence as well (adjusted hazard ratio = 1.24, P = .672). In a propensity score-matching analysis, a microscopically positive margin did not increase the risk of locoregional recurrence. Conclusion: Microscopic involvement of the operative margin in papillary thyroid cancer patients, whether anteriorly or posteriorly, does not appear be an independent prognostic factor in recurrencefree survival rates. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:1160 / 1167
页数:8
相关论文
共 50 条
  • [21] Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? Editorial comment
    Zincke, H
    JOURNAL OF UROLOGY, 2002, 167 (01): : 64 - 64
  • [22] Vitamin D and cancer: does it really matter?
    Scaranti, Mariana
    de Castro Junior, Gilberto
    Hoff, Ana Oliveira
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (03) : 205 - 209
  • [23] Thyroid Cancer: Does the Size Matter?
    Pitoia, Fabian
    Niepomniszcze, Hugo
    THYROID, 2008, 18 (12) : 1337 - 1337
  • [24] Regional Node Distribution in Papillary Thyroid Cancer with Microscopic Metastasis
    Hurtado-Lopez, Luis-Mauricio
    Ordonez-Rueda, Alejandro
    Zaldivar-Ramirez, Felipe-Rafael
    Basurto-Kuba, Erich
    JOURNAL OF THYROID RESEARCH, 2018, 2018
  • [25] Microscopic Positive Tumor Margin Increases Risk for Disease Persistence but Not Recurrence in Patients with Stage T1-T2 Differentiated Thyroid Cancer
    Hasan, Olfat Kamel
    De Brabandere, Sarah
    Rachinsky, Irina
    Laidley, David
    MacNeil, Danielle
    Van Uum, Stan
    JOURNAL OF THYROID RESEARCH, 2020, 2020
  • [26] An impact of microscopic positive margin on incomplete response after I-131 treatment in differentiated thyroid cancer
    Yutapong Raruenrom
    Katanyoo Sawangsri
    Charoonsak Somboonporn
    Daris Theerakulpisut
    Nantaporn Wongsurawat
    Teeraporn Ratanaanekchai
    Annals of Nuclear Medicine, 2020, 34 : 453 - 459
  • [27] An impact of microscopic positive margin on incomplete response after I-131 treatment in differentiated thyroid cancer
    Raruenrom, Yutapong
    Sawangsri, Katanyoo
    Somboonporn, Charoonsak
    Theerakulpisut, Daris
    Wongsurawat, Nantaporn
    Ratanaanekchai, Teeraporn
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (07) : 453 - 459
  • [28] Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
    Abdulrezzak, Ummuhan
    Tutus, Ahmet
    Kula, Mustafa
    Ozturk, Figen
    Soyuer, Isin
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2012, 21 (01) : 38 - 41
  • [29] Encapsulated follicular variant of papillary thyroid cancer: are these tumors really benign?
    Aburjania, Zviadi
    Jang, Samuel
    Montemayor-Garcia, Celina
    Lloyd, Ricardo V.
    Schneider, David F.
    Sippel, Rebecca S.
    Chen, Herbert
    Elfenbein, Dawn M.
    JOURNAL OF SURGICAL RESEARCH, 2017, 216 : 138 - 142
  • [30] Isolated Lateral Neck Nodal Metastases in Patients With Papillary Thyroid Cancer: Does Cervical Compartment Matter?
    Ullmann, Timothy M.
    Quan-Yang Duh
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (08): : E3534 - E3535